176 related articles for article (PubMed ID: 11823524)
1. IL-4 up-regulates the expression of tissue inhibitor of metalloproteinase-2 in dermal fibroblasts via the p38 mitogen-activated protein kinase dependent pathway.
Ihn H; Yamane K; Asano Y; Kubo M; Tamaki K
J Immunol; 2002 Feb; 168(4):1895-902. PubMed ID: 11823524
[TBL] [Abstract][Full Text] [Related]
2. An inhibitor of stress-activated MAP-kinases reduces invasion and MMP-2 expression of malignant melanoma cells.
Denkert C; Siegert A; Leclere A; Turzynski A; Hauptmann S
Clin Exp Metastasis; 2002; 19(1):79-85. PubMed ID: 11918086
[TBL] [Abstract][Full Text] [Related]
3. Modulation of phorbol ester-induced regulation of matrix metalloproteinases and tissue inhibitors of metalloproteinases by SB203580, a specific inhibitor of p38 mitogen-activated protein kinase.
Park MJ; Park IC; Hur JH; Kim MS; Lee HC; Woo SH; Lee KH; Rhee CH; Hong SI; Lee SH
J Neurosurg; 2002 Jul; 97(1):112-8. PubMed ID: 12134900
[TBL] [Abstract][Full Text] [Related]
4. Activation of p38 MAPK suppresses matrix metalloproteinase-1 gene expression induced by platelet-derived growth factor.
Endo H; Utani A; Shinkai H
Arch Dermatol Res; 2003 Mar; 294(12):552-8. PubMed ID: 12624781
[TBL] [Abstract][Full Text] [Related]
5. Bradykinin stimulates IL-6 and IL-8 production by human lung fibroblasts through ERK- and p38 MAPK-dependent mechanisms.
Hayashi R; Yamashita N; Matsui S; Fujita T; Araya J; Sassa K; Arai N; Yoshida Y; Kashii T; Maruyama M; Sugiyama E; Kobayashi M
Eur Respir J; 2000 Sep; 16(3):452-8. PubMed ID: 11028659
[TBL] [Abstract][Full Text] [Related]
6. Increased phosphorylation and activation of mitogen-activated protein kinase p38 in scleroderma fibroblasts.
Ihn H; Yamane K; Tamaki K
J Invest Dermatol; 2005 Aug; 125(2):247-55. PubMed ID: 16098034
[TBL] [Abstract][Full Text] [Related]
7. Actions of IL-1 are selectively controlled by p38 mitogen-activated protein kinase: regulation of prostaglandin H synthase-2, metalloproteinases, and IL-6 at different levels.
Ridley SH; Sarsfield SJ; Lee JC; Bigg HF; Cawston TE; Taylor DJ; DeWitt DL; Saklatvala J
J Immunol; 1997 Apr; 158(7):3165-73. PubMed ID: 9120270
[TBL] [Abstract][Full Text] [Related]
8. Oncostatin M-induced matrix metalloproteinase and tissue inhibitor of metalloproteinase-3 genes expression in chondrocytes requires Janus kinase/STAT signaling pathway.
Li WQ; Dehnade F; Zafarullah M
J Immunol; 2001 Mar; 166(5):3491-8. PubMed ID: 11207308
[TBL] [Abstract][Full Text] [Related]
9. Distinct role of p38 and c-Jun N-terminal kinases in IL-10-dependent and IL-10-independent regulation of the costimulatory molecule B7.2 in lipopolysaccharide-stimulated human monocytic cells.
Lim W; Ma W; Gee K; Aucoin S; Nandan D; Diaz-Mitoma F; Kozlowski M; Kumar A
J Immunol; 2002 Feb; 168(4):1759-69. PubMed ID: 11823508
[TBL] [Abstract][Full Text] [Related]
10. Mitogen-activated protein kinases Erk1/2 and p38 are required for maximal regulation of TIMP-1 by oncostatin M in murine fibroblasts.
Tong L; Smyth D; Kerr C; Catterall J; Richards CD
Cell Signal; 2004 Oct; 16(10):1123-32. PubMed ID: 15240007
[TBL] [Abstract][Full Text] [Related]
11. Induction of VEGF gene transcription by IL-1 beta is mediated through stress-activated MAP kinases and Sp1 sites in cardiac myocytes.
Tanaka T; Kanai H; Sekiguchi K; Aihara Y; Yokoyama T; Arai M; Kanda T; Nagai R; Kurabayashi M
J Mol Cell Cardiol; 2000 Nov; 32(11):1955-67. PubMed ID: 11040101
[TBL] [Abstract][Full Text] [Related]
12. IL-1 induces collagenase-3 (MMP-13) promoter activity in stably transfected chondrocytic cells: requirement for Runx-2 and activation by p38 MAPK and JNK pathways.
Mengshol JA; Vincenti MP; Brinckerhoff CE
Nucleic Acids Res; 2001 Nov; 29(21):4361-72. PubMed ID: 11691923
[TBL] [Abstract][Full Text] [Related]
13. Role of mitogen-activated protein kinase in the regulation of transforming growth factor-beta-induced fibronectin accumulation in cultured renal interstitial fibroblasts.
Suzuki H; Uchida K; Nitta K; Nihei H
Clin Exp Nephrol; 2004 Sep; 8(3):188-95. PubMed ID: 15480895
[TBL] [Abstract][Full Text] [Related]
14. The involvement of tyrosine kinases, cyclic AMP/protein kinase A, and p38 mitogen-activated protein kinase in IL-13-mediated arginase I induction in macrophages: its implications in IL-13-inhibited nitric oxide production.
Chang CI; Zoghi B; Liao JC; Kuo L
J Immunol; 2000 Aug; 165(4):2134-41. PubMed ID: 10925299
[TBL] [Abstract][Full Text] [Related]
15. Infrared-A radiation-induced matrix metalloproteinase 1 expression is mediated through extracellular signal-regulated kinase 1/2 activation in human dermal fibroblasts.
Schieke S; Stege H; Kürten V; Grether-Beck S; Sies H; Krutmann J
J Invest Dermatol; 2002 Dec; 119(6):1323-9. PubMed ID: 12485435
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-beta induces collagenase-3 expression by human gingival fibroblasts via p38 mitogen-activated protein kinase.
Ravanti L; Häkkinen L; Larjava H; Saarialho-Kere U; Foschi M; Han J; Kähäri VM
J Biol Chem; 1999 Dec; 274(52):37292-300. PubMed ID: 10601295
[TBL] [Abstract][Full Text] [Related]
17. Role of MAP kinase pathways in mediating IL-6 production in human primary mesangial and proximal tubular cells.
Leonard M; Ryan MP; Watson AJ; Schramek H; Healy E
Kidney Int; 1999 Oct; 56(4):1366-77. PubMed ID: 10504489
[TBL] [Abstract][Full Text] [Related]
18. Amplification of IL-1 beta-induced matrix metalloproteinase-9 expression by superoxide in rat glomerular mesangial cells is mediated by increased activities of NF-kappa B and activating protein-1 and involves activation of the mitogen-activated protein kinase pathways.
Eberhardt W; Huwiler A; Beck KF; Walpen S; Pfeilschifter J
J Immunol; 2000 Nov; 165(10):5788-97. PubMed ID: 11067938
[TBL] [Abstract][Full Text] [Related]
19. p38 mitogen-activated protein kinase regulates human T cell IL-5 synthesis.
Mori A; Kaminuma O; Miyazawa K; Ogawa K; Okudaira H; Akiyama K
J Immunol; 1999 Nov; 163(9):4763-71. PubMed ID: 10528175
[TBL] [Abstract][Full Text] [Related]
20. Role of p38 MAPK in transforming growth factor beta stimulation of collagen production by scleroderma and healthy dermal fibroblasts.
Sato M; Shegogue D; Gore EA; Smith EA; McDermott PJ; Trojanowska M
J Invest Dermatol; 2002 Apr; 118(4):704-11. PubMed ID: 11918720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
